| 7/27/2022 3:17 pm Date / Time filed with the Register of Regulations | VA.R. Document Number: R____-______ |
|
Virginia Register Publication Information
|
Transmittal Sheet: Response to Petition for Rulemaking
X
Initial Agency Notice
Agency Decision
| Promulgating Board: | Board of Medicine |
| Regulatory Coordinator: | Erin Barrett (804)367-4688 erin.barrett@dhp.virginia.gov |
| Agency Contact: | William L. Harp, M.D. Executive Director (804)367-4558 william.harp@dhp.virginia.gov |
| Contact Address: | Department of Health Professions 9960 Mayland Drive Suite 300 Henrico, VA 23233 |
| Chapter Affected: | |
| 18 vac 85 - 21: | Regulations Governing Prescribing of Opioids and Buprenorphine |
| Statutory Authority: |
State: 54.1-2400 and 54.1-2928.2 Federal: |
| Date Petition Received | 07/27/2022 |
| Petitioner | Todd Lacksonen |
The petitioner requests that the Board amend 18VAC85-21-40 to replace the requirement
to co-prescribe naloxone with certain medications or conditions with a requirement
to co-prescribe an FDA-approved opioid-reversal agent.
Agency Plan
The petition for rulemaking will be published in the Virginia Register of Regulations
on August 29, 2022. The petition will also be published on the Virginia Regulatory
Town Hall at www.townhall.virginia.gov to receive public comment, which will open
on August 29, 2022 and will close on September 19, 2022. The Board will consider the
petition and all comments in support or opposition at the next meeting after the close
of public comment, currently scheduled for October 6, 2022.
| Publication Date | 08/29/2022 (comment period will also begin on this date) |
| Comment End Date | 09/19/2022 |